DD129790A5 - Verfahren zur herstellung von phenylpiperazinderivaten - Google Patents

Verfahren zur herstellung von phenylpiperazinderivaten

Info

Publication number
DD129790A5
DD129790A5 DD7700198558A DD19855877A DD129790A5 DD 129790 A5 DD129790 A5 DD 129790A5 DD 7700198558 A DD7700198558 A DD 7700198558A DD 19855877 A DD19855877 A DD 19855877A DD 129790 A5 DD129790 A5 DD 129790A5
Authority
DD
German Democratic Republic
Prior art keywords
preparation
phenylpiperazine derivatives
phenylpiperazine
derivatives
Prior art date
Application number
DD7700198558A
Other languages
German (de)
English (en)
Inventor
William B Jamieson
John P Verge
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of DD129790A5 publication Critical patent/DD129790A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40Radicals substituted by oxygen atoms
    • C07D307/42Singly bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DD7700198558A 1976-04-23 1977-04-22 Verfahren zur herstellung von phenylpiperazinderivaten DD129790A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB16526/76A GB1575904A (en) 1976-04-23 1976-04-23 Phenyl piperazines

Publications (1)

Publication Number Publication Date
DD129790A5 true DD129790A5 (de) 1978-02-08

Family

ID=10078930

Family Applications (1)

Application Number Title Priority Date Filing Date
DD7700198558A DD129790A5 (de) 1976-04-23 1977-04-22 Verfahren zur herstellung von phenylpiperazinderivaten

Country Status (34)

Country Link
JP (1) JPS52151183A (es)
AR (2) AR222003A1 (es)
AT (1) AT355579B (es)
AU (1) AU514822B2 (es)
BE (1) BE853899A (es)
BG (2) BG28055A3 (es)
CA (1) CA1087617A (es)
CH (2) CH625802A5 (es)
CS (1) CS196360B2 (es)
DD (1) DD129790A5 (es)
DE (1) DE2717415A1 (es)
DK (1) DK176177A (es)
ES (2) ES457988A1 (es)
FI (1) FI63937C (es)
FR (1) FR2348925A1 (es)
GB (1) GB1575904A (es)
GR (1) GR64084B (es)
HU (1) HU176820B (es)
IE (1) IE44730B1 (es)
IL (1) IL51787A (es)
LU (1) LU77170A1 (es)
MX (1) MX4596E (es)
NL (1) NL7704456A (es)
NO (1) NO146710C (es)
NZ (1) NZ183715A (es)
OA (1) OA05643A (es)
PH (1) PH14124A (es)
PL (1) PL117466B1 (es)
PT (1) PT66452B (es)
RO (1) RO72831A (es)
SE (1) SE7704536L (es)
SU (2) SU664564A3 (es)
YU (1) YU104477A (es)
ZA (1) ZA771849B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1601310A (en) * 1978-05-23 1981-10-28 Lilly Industries Ltd Aryl hydantoins
DE3142608A1 (de) * 1981-10-28 1983-05-05 Basf Ag, 6700 Ludwigshafen Polyazofarbstoffe
JPH07157477A (ja) * 1993-12-02 1995-06-20 Asahi Kagaku Kogyo Kk チアゾール誘導体の製造方法
WO1995024399A1 (fr) * 1994-03-11 1995-09-14 Yamanouchi Pharmaceutical Co., Ltd. Agoniste de recepteur 5-ht3, nouveau derive de thiazole et intermediaire destine a son obtention
GB9517381D0 (en) * 1995-08-24 1995-10-25 Pharmacia Spa Aryl and heteroaryl piperazine derivatives
SG171635A1 (en) * 2006-02-28 2011-06-29 Helicon Therapeutics Inc Therapeutic piperazines as pde4 inhibitors
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines

Also Published As

Publication number Publication date
AU2438677A (en) 1978-10-26
PL117466B1 (en) 1981-08-31
AR222003A1 (es) 1981-04-15
NO146710B (no) 1982-08-16
BE853899A (fr) 1977-10-24
CS196360B2 (en) 1980-03-31
ES457988A1 (es) 1978-07-16
PT66452A (en) 1977-05-01
JPS52151183A (en) 1977-12-15
GB1575904A (en) 1980-10-01
SU727146A3 (ru) 1980-04-05
CH625802A5 (en) 1981-10-15
RO72831A (ro) 1983-08-03
NL7704456A (nl) 1977-10-25
BG28055A3 (en) 1980-02-25
SU664564A3 (ru) 1979-05-25
YU104477A (en) 1983-01-21
AU514822B2 (en) 1981-02-26
AR222635A1 (es) 1981-06-15
MX4596E (es) 1982-06-25
PT66452B (en) 1979-03-09
ATA285177A (de) 1979-08-15
ZA771849B (en) 1978-11-29
IE44730B1 (en) 1982-03-10
HU176820B (en) 1981-05-28
IE44730L (en) 1977-10-23
PL197550A1 (pl) 1979-05-21
AT355579B (de) 1980-03-10
FI63937B (fi) 1983-05-31
NO146710C (no) 1982-11-24
GR64084B (en) 1980-01-21
OA05643A (fr) 1981-04-30
FI63937C (fi) 1983-09-12
CA1087617A (en) 1980-10-14
LU77170A1 (es) 1979-01-18
FI771287A (es) 1977-10-24
ES467948A1 (es) 1978-11-01
CH633009A5 (en) 1982-11-15
IL51787A (en) 1980-02-29
FR2348925A1 (fr) 1977-11-18
FR2348925B1 (es) 1980-04-11
DE2717415A1 (de) 1977-11-10
DK176177A (da) 1977-10-24
RO72831B (ro) 1983-07-30
IL51787A0 (en) 1977-05-31
NZ183715A (en) 1980-04-28
NO771398L (no) 1977-10-25
BG27746A3 (en) 1979-12-12
PH14124A (en) 1981-02-26
SE7704536L (sv) 1977-10-24

Similar Documents

Publication Publication Date Title
DD134526A5 (de) Verfahren zur herstellung von alkyloxinderivaten der 7-aminothiazolylazetamidozephalosporansaeure
DD133680A5 (de) Verfahren zur herstellung von polyaetherpolyolen
DD128672A5 (de) Verfahren zur herstellung von m-aryloxybenzaldehyden
DD132015A5 (de) Verfahren zur herstellung von trans-hexahydro-pyrido-indolen
AT348995B (de) Verfahren zur herstellung von acylcyaniden
DD129777A5 (de) Verfahren zur herstellung von phenoxypropionsaeurederivaten
DD128659A5 (de) Verfahren zur herstellung von 4-androsten-3-onen
AT347926B (de) Verfahren zur herstellung von acylcyaniden
DD132429A5 (de) Verfahren zur herstellung von derivaten von phenoxyalkansaeuren
DD131018A5 (de) Verfahren zur herstellung von 2-chlorsulfinylazetidin-4-onen
DD129903A5 (de) Verfahren zur herstellung von benzoylcyanid
DD133795A5 (de) Verfahren zur herstellung von 4a-aryloctahydro-1h-2-pyrindinen
DD132013A5 (de) Verfahren zur herstellung von benzoylcyanid
DD129790A5 (de) Verfahren zur herstellung von phenylpiperazinderivaten
AT348509B (de) Verfahren zur herstellung von acylcyaniden
DD130241A5 (de) Verfahren zur herstellung von benzoylcyanid
PT67048B (de) Verfahren zur herstellung von 1-amino-2-hydroxy-3-heterocyclyloxy-propanen
DD129785A5 (de) Verfahren zur herstellung von indazolderivaten
ATA312477A (de) Verfahren zur herstellung von cholecystokinin- -pancreozymin-octapeptidamid-sulfatester
DD128591A5 (de) Verfahren zur herstellung von 2-oxo-1-pyrrolidinen
DD129915A5 (de) Verfahren zur herstellung von 7-alkoxy-3-chlormethyl-3-cephemen
DD128953A1 (de) Verfahren zur herstellung von alkalizellulose
DD134085A5 (de) Verfahren zur herstellung von halogenacylamiden
DD135485A5 (de) Verfahren zur herstellung von nitroalkanolderivaten
DD129792A5 (de) Verfahren zur herstellung von 1-oxadethiacephalosporinen